-
Je něco špatně v tomto záznamu ?
Oligomerization of adenosin-5'-O-ylmethylphosphonate, an isopolar AMP analogue: evaluation of the route to short oligoadenylates
M. Pressová, M. Buděšínský, I. Košiová, V. Kopecký, J. Cvačka, V. Kašička, O. Šimák, Z. Točík, I. Rosenberg
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Wiley Online Library (archiv)
od 1996-01-01 do 2012-12-31
Wiley Online Library (archiv)
od 1996-01-01 do 2012-12-31
PubMed
19844977
DOI
10.1002/bip.21329
Knihovny.cz E-zdroje
- MeSH
- adeninnukleotidy chemie metabolismus MeSH
- adenosinmonofosfát analogy a deriváty MeSH
- molekulární modely MeSH
- molekulární struktura MeSH
- nukleární magnetická rezonance biomolekulární MeSH
- oligoribonukleotidy chemie metabolismus MeSH
- oxidace-redukce MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
In an attempt to prepare a library of short oligoadenylate analogues featuring both the enzyme-stable internucleotide linkage and the 5'-O-methylphosphonate moiety and thus obtain a pool of potential RNase L agonists/antagonists, we studied the spontaneous polycondensation of the adenosin-5'-O-ylmethylphosphonic acid (p(c)A), an isopolar AMP analogue, and its imidazolide derivatives employing N,N'-dicyclohexylcarbodiimide under nonaqueous conditions and uranyl ions under aqueous conditions, respectively. The RP LC-MS analyses of the reaction mixtures per se, and those obtained after the periodate treatment, along with analyses and separations by capillary zone electrophoresis, allowed us to characterize major linear and cyclic oligoadenylates obtained. The structure of selected compounds was supported, after their isolation, by NMR spectroscopy. Ab initio calculation of the model structures simulating the AMP-imidazolide and p(c)A-imidazolide offered the explanation why the latter compound exerted, in contrast to AMP-imidazolide, a very low stability in aqueous solutions.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025504
- 003
- CZ-PrNML
- 005
- 20130225193939.0
- 007
- ta
- 008
- 120816s2010 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1002/bip.21329 $2 doi
- 035 __
- $a (PubMed)19844977
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pressová, Martina $7 xx0128417 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences, v. v. i., Flemingovo 2, 16610 Prague 6, Czech Republic.
- 245 10
- $a Oligomerization of adenosin-5'-O-ylmethylphosphonate, an isopolar AMP analogue: evaluation of the route to short oligoadenylates / $c M. Pressová, M. Buděšínský, I. Košiová, V. Kopecký, J. Cvačka, V. Kašička, O. Šimák, Z. Točík, I. Rosenberg
- 520 9_
- $a In an attempt to prepare a library of short oligoadenylate analogues featuring both the enzyme-stable internucleotide linkage and the 5'-O-methylphosphonate moiety and thus obtain a pool of potential RNase L agonists/antagonists, we studied the spontaneous polycondensation of the adenosin-5'-O-ylmethylphosphonic acid (p(c)A), an isopolar AMP analogue, and its imidazolide derivatives employing N,N'-dicyclohexylcarbodiimide under nonaqueous conditions and uranyl ions under aqueous conditions, respectively. The RP LC-MS analyses of the reaction mixtures per se, and those obtained after the periodate treatment, along with analyses and separations by capillary zone electrophoresis, allowed us to characterize major linear and cyclic oligoadenylates obtained. The structure of selected compounds was supported, after their isolation, by NMR spectroscopy. Ab initio calculation of the model structures simulating the AMP-imidazolide and p(c)A-imidazolide offered the explanation why the latter compound exerted, in contrast to AMP-imidazolide, a very low stability in aqueous solutions.
- 650 _2
- $a adeninnukleotidy $x chemie $x metabolismus $7 D000227
- 650 _2
- $a adenosinmonofosfát $x analogy a deriváty $7 D000249
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a nukleární magnetická rezonance biomolekulární $7 D019906
- 650 _2
- $a oligoribonukleotidy $x chemie $x metabolismus $7 D009843
- 650 _2
- $a oxidace-redukce $7 D010084
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Buděšínský, Miloš, $d 1944- $7 jn20010309100
- 700 1#
- $a Košiová, Ivana. $7 _AN071445
- 700 1#
- $a Kopecký, Vladimír, $c jr., $d 1974- $7 xx0022663
- 700 1_
- $a Cvačka, Josef $7 xx0110454
- 700 1_
- $a Kašička, Václav, $d 1952- $7 xx0081263
- 700 1_
- $a Šimák, Ondřej $7 xx0125278
- 700 1_
- $a Točík, Zdeněk, $d 1946- $7 xx0104716
- 700 1_
- $a Rosenberg, Ivan, $d 1948- $7 xx0086095
- 773 0_
- $w MED00000777 $t Biopolymers $x 0006-3525 $g Roč. 93, č. 3 (2010), s. 277-289
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/19844977 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130225194152 $b ABA008
- 999 __
- $a ok $b bmc $g 947546 $s 782850
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 93 $c 3 $d 277-289 $i 0006-3525 $m Biopolymers $n Biopolymers $x MED00000777
- LZP __
- $a Pubmed-20120816/10/02